William B. Coley Award: Difference between revisions

Content deleted Content added

Inline

Revision as of 15:20, 9 June 2009

The William B. Coley Award for Distinguished Research in Basic and Tumor Immunology is presented annually by the Cancer Research Institute, to scientists who have made outstanding achievements in the fields of basic and tumor immunology and whose work has deepened our understanding of the immune system's response to disease, including cancer.

The first awards were made in 1975 to a group of 16 scientists called the "Founders of Cancer Immunology." In 1993, the award was renamed after Dr. William B. Coley^[1], a late-nineteenth century surgeon who made the first attempts at the non-surgical treatment of cancer through stimulation of the immune system. For this reason, Dr. Coley has become known as the "Father of Cancer Immunotherapy."

Recipients

2009
For Distinguished Research in Tumor Immunology

Cornelis J.M. Melief, M.D., Ph.D.

For Distinguished Research in Basic Immunology (joint prize)

Frederick K. Alt, Ph.D.
Klaus Rajewsky, M.D.

2008

Michael J. Bevan, Ph.D., FRS

2007

Jeffrey V. Ravetch

2006

2005

James P. Allison

2004

2003

2002

2001

Robert D. Schreiber

2000

1999

1998

1997

1996

Giorgio Trinchieri

1995

1993

1989

1987

1983

Richard K. Gershon

1979

1978

1975

References

^ http://www.cancerresearch.org/history.html

[1] ttp://www.cancerresearch.org/history.html

[1]

Revision as of 00:54, 9 June 2009 edit 24.215.238.14 (talk) →‎Recipients ← Previous edit		Revision as of 15:20, 9 June 2009 edit undo 69.176.216.130 (talk) edit first paragraph, Cancer Research Institute description Next edit →
Line 1:		Line 1:
	The '''William B. Coley Award for Distinguished Research in Basic and Tumor Immunology''' is presented annually by ~~the U.S. nonprofit organization,~~ the [http://www.cancerresearch.org Cancer Research Institute], to scientists who have made outstanding achievements in the fields of basic and tumor immunology and whose work has deepened our understanding of the immune system's response to disease, including cancer.		The '''William B. Coley Award for Distinguished Research in Basic and Tumor Immunology''' is presented annually by the [http://www.cancerresearch.org/ Cancer Research Institute], to scientists who have made outstanding achievements in the fields of basic and tumor immunology and whose work has deepened our understanding of the immune system's response to disease, including cancer.

	The first awards were made in 1975 to a group of 16 scientists called the "Founders of Cancer Immunology." In 1993, the award was renamed after [[William B. Coley\|Dr. William B. Coley]]<ref>http://www.cancerresearch.org/history.html</ref>, a late-nineteenth century surgeon who made the first attempts at the non-surgical treatment of cancer through stimulation of the immune system. For this reason, Dr. Coley has become known as the "Father of Cancer Immunotherapy."		The first awards were made in 1975 to a group of 16 scientists called the "Founders of Cancer Immunology." In 1993, the award was renamed after [[William B. Coley\|Dr. William B. Coley]]<ref>http://www.cancerresearch.org/history.html</ref>, a late-nineteenth century surgeon who made the first attempts at the non-surgical treatment of cancer through stimulation of the immune system. For this reason, Dr. Coley has become known as the "Father of Cancer Immunotherapy."